The global market for Parenteral Dosage Form was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents鈥� wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Parenteral Dosage Form, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Parenteral Dosage Form.
The Parenteral Dosage Form market size, estimations, and forecasts are provided in terms of sales volume (Kiloton) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Parenteral Dosage Form market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Parenteral Dosage Form manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Ashland
Tepnel Pharma Services
Ascendia Pharmaceuticals
Thermo Fisher Scientific
ProJect Pharmaceutics
Lonza
BOC Sciences
Segment by Type
Emulsions for Injection
Powders for Injection
Gels for Injection
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Parenteral Dosage Form manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Parenteral Dosage Form in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Parenteral Dosage Form 麻豆原创 Overview
1.1 Product Definition
1.2 Parenteral Dosage Form by Type
1.2.1 Global Parenteral Dosage Form 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 Emulsions for Injection
1.2.3 Powders for Injection
1.2.4 Gels for Injection
1.3 Parenteral Dosage Form by Application
1.3.1 Global Parenteral Dosage Form 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Parenteral Dosage Form 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Parenteral Dosage Form Revenue 2020-2031
1.4.2 Global Parenteral Dosage Form Sales 2020-2031
1.4.3 Global Parenteral Dosage Form 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Parenteral Dosage Form 麻豆原创 Competition by Manufacturers
2.1 Global Parenteral Dosage Form Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Parenteral Dosage Form Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Parenteral Dosage Form Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Parenteral Dosage Form, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Parenteral Dosage Form, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Parenteral Dosage Form, Product Type & Application
2.7 Global Key Manufacturers of Parenteral Dosage Form, Date of Enter into This Industry
2.8 Global Parenteral Dosage Form 麻豆原创 Competitive Situation and Trends
2.8.1 Global Parenteral Dosage Form 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Parenteral Dosage Form Players 麻豆原创 Share by Revenue
2.8.3 Global Parenteral Dosage Form 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Parenteral Dosage Form 麻豆原创 Scenario by Region
3.1 Global Parenteral Dosage Form 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Parenteral Dosage Form Sales by Region: 2020-2031
3.2.1 Global Parenteral Dosage Form Sales by Region: 2020-2025
3.2.2 Global Parenteral Dosage Form Sales by Region: 2026-2031
3.3 Global Parenteral Dosage Form Revenue by Region: 2020-2031
3.3.1 Global Parenteral Dosage Form Revenue by Region: 2020-2025
3.3.2 Global Parenteral Dosage Form Revenue by Region: 2026-2031
3.4 North America Parenteral Dosage Form 麻豆原创 Facts & Figures by Country
3.4.1 North America Parenteral Dosage Form 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Parenteral Dosage Form Sales by Country (2020-2031)
3.4.3 North America Parenteral Dosage Form Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Parenteral Dosage Form 麻豆原创 Facts & Figures by Country
3.5.1 Europe Parenteral Dosage Form 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Parenteral Dosage Form Sales by Country (2020-2031)
3.5.3 Europe Parenteral Dosage Form Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Parenteral Dosage Form 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Parenteral Dosage Form 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Parenteral Dosage Form Sales by Region (2020-2031)
3.6.3 Asia Pacific Parenteral Dosage Form Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Parenteral Dosage Form 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Parenteral Dosage Form 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Parenteral Dosage Form Sales by Country (2020-2031)
3.7.3 Latin America Parenteral Dosage Form Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Parenteral Dosage Form 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Parenteral Dosage Form 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Parenteral Dosage Form Sales by Country (2020-2031)
3.8.3 Middle East and Africa Parenteral Dosage Form Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Parenteral Dosage Form Sales by Type (2020-2031)
4.1.1 Global Parenteral Dosage Form Sales by Type (2020-2025)
4.1.2 Global Parenteral Dosage Form Sales by Type (2026-2031)
4.1.3 Global Parenteral Dosage Form Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global Parenteral Dosage Form Revenue by Type (2020-2031)
4.2.1 Global Parenteral Dosage Form Revenue by Type (2020-2025)
4.2.2 Global Parenteral Dosage Form Revenue by Type (2026-2031)
4.2.3 Global Parenteral Dosage Form Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global Parenteral Dosage Form Price by Type (2020-2031)
5 Segment by Application
5.1 Global Parenteral Dosage Form Sales by Application (2020-2031)
5.1.1 Global Parenteral Dosage Form Sales by Application (2020-2025)
5.1.2 Global Parenteral Dosage Form Sales by Application (2026-2031)
5.1.3 Global Parenteral Dosage Form Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global Parenteral Dosage Form Revenue by Application (2020-2031)
5.2.1 Global Parenteral Dosage Form Revenue by Application (2020-2025)
5.2.2 Global Parenteral Dosage Form Revenue by Application (2026-2031)
5.2.3 Global Parenteral Dosage Form Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global Parenteral Dosage Form Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Ashland
6.1.1 Ashland Company Information
6.1.2 Ashland Description and Business Overview
6.1.3 Ashland Parenteral Dosage Form Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Ashland Parenteral Dosage Form Product Portfolio
6.1.5 Ashland Recent Developments/Updates
6.2 Tepnel Pharma Services
6.2.1 Tepnel Pharma Services Company Information
6.2.2 Tepnel Pharma Services Description and Business Overview
6.2.3 Tepnel Pharma Services Parenteral Dosage Form Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Tepnel Pharma Services Parenteral Dosage Form Product Portfolio
6.2.5 Tepnel Pharma Services Recent Developments/Updates
6.3 Ascendia Pharmaceuticals
6.3.1 Ascendia Pharmaceuticals Company Information
6.3.2 Ascendia Pharmaceuticals Description and Business Overview
6.3.3 Ascendia Pharmaceuticals Parenteral Dosage Form Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Ascendia Pharmaceuticals Parenteral Dosage Form Product Portfolio
6.3.5 Ascendia Pharmaceuticals Recent Developments/Updates
6.4 Thermo Fisher Scientific
6.4.1 Thermo Fisher Scientific Company Information
6.4.2 Thermo Fisher Scientific Description and Business Overview
6.4.3 Thermo Fisher Scientific Parenteral Dosage Form Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Thermo Fisher Scientific Parenteral Dosage Form Product Portfolio
6.4.5 Thermo Fisher Scientific Recent Developments/Updates
6.5 ProJect Pharmaceutics
6.5.1 ProJect Pharmaceutics Company Information
6.5.2 ProJect Pharmaceutics Description and Business Overview
6.5.3 ProJect Pharmaceutics Parenteral Dosage Form Sales, Revenue and Gross Margin (2020-2025)
6.5.4 ProJect Pharmaceutics Parenteral Dosage Form Product Portfolio
6.5.5 ProJect Pharmaceutics Recent Developments/Updates
6.6 Lonza
6.6.1 Lonza Company Information
6.6.2 Lonza Description and Business Overview
6.6.3 Lonza Parenteral Dosage Form Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Lonza Parenteral Dosage Form Product Portfolio
6.6.5 Lonza Recent Developments/Updates
6.7 BOC Sciences
6.7.1 BOC Sciences Company Information
6.7.2 BOC Sciences Description and Business Overview
6.7.3 BOC Sciences Parenteral Dosage Form Sales, Revenue and Gross Margin (2020-2025)
6.7.4 BOC Sciences Parenteral Dosage Form Product Portfolio
6.7.5 BOC Sciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Parenteral Dosage Form Industry Chain Analysis
7.2 Parenteral Dosage Form Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Parenteral Dosage Form Production Mode & Process Analysis
7.4 Parenteral Dosage Form Sales and 麻豆原创ing
7.4.1 Parenteral Dosage Form Sales Channels
7.4.2 Parenteral Dosage Form Distributors
7.5 Parenteral Dosage Form Customer Analysis
8 Parenteral Dosage Form 麻豆原创 Dynamics
8.1 Parenteral Dosage Form Industry Trends
8.2 Parenteral Dosage Form 麻豆原创 Drivers
8.3 Parenteral Dosage Form 麻豆原创 Challenges
8.4 Parenteral Dosage Form 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Ashland
Tepnel Pharma Services
Ascendia Pharmaceuticals
Thermo Fisher Scientific
ProJect Pharmaceutics
Lonza
BOC Sciences
听
听
*If Applicable.